Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation-Reference-Cited by-同舟云学术

Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation

Published:2014-01 Issue: Volume:18 Page:62-67
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Xie Jiao,Wang Taotao,Sun Jinyao,Chen Siying,Cai Jiangxia,Zhang Weipeng,Dong Haiyan,Hu Sasa,Zhang Di,Wang Xue,Dong Yalin

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data;Babinchak;Clin Infect Dis,2005

2. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections;Bradford;Clin Infect Dis,2005

3. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin–aztreonam;Ellis-Grosse;Clin Infect Dis,2005

4. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates;Petersen;Antimicrob Agents Chemother,2005

5. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004–2010;Balode;Int J Antimicrob Agents,2013

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling;Frontiers in Pharmacology;2024-01-29

2. Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection;Biomedical Reports;2023-06-13

3. Pharmacokinetic/Pharmacodynamic Target Attainment of Tigecycline in Patients with Hepatic Impairment in a Real-World Setting;Therapeutic Drug Monitoring;2023-06-02

4. Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation;Antibiotics;2023-02-02

5. Assessment of the activity of tigecycline and colistin on biofilm producer Klebsiella pneumoniae isolated from COVID-19 patients, Iran;2023-01-10